Combining two
different immunotherapy treatments could dramatically improve lymphoma survival.
Not exact matches
Schlom, of the National Cancer Institute, says the next challenge for researchers is to find ways to combine
different immunotherapy drugs into single
treatments and measure their efficacy in clinical trials.
ALEXANDRIA, VA, FORT WASHINGTON, PA. —
Immunotherapy with immune checkpoint inhibitors is the first of a new generation of immunotherapy treatments, revolutionizing treatment for many different typ
Immunotherapy with immune checkpoint inhibitors is the first of a new generation of
immunotherapy treatments, revolutionizing treatment for many different typ
immunotherapy treatments, revolutionizing
treatment for many
different types of cancer.
The other major class of
immunotherapies are known as anti-CTLA-4
treatments, such as ipilimumab (Yervoy), which target a
different mechanism to unleash immune cells to fight tumors.
Immunotherapy is a broad category of anti-cancer
treatment which can be grouped into four
different subcategories:
Several
different types of
immunotherapy are currently being explored for the
treatment of leukemia.
There are several
different treatments being compared, including: surgery followed by vaccine - based
immunotherapy, surgery followed by oncolytic virus therapy, surgery followed by IL - 12 gene therapy and biopsy followed by placement of a specialized catheter system that draws tumor cells out of the brain.